Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

quietx.com

Stage

Series A | Alive

Total Raised

$5.5M

Last Raised

$5.5M | 10 yrs ago

About Quiet Therapeutics

Quiet Therapeutics, founded in 2010 is developing novel siRNA delivery solutions. Its proprietary GAGomer nanoparticles are unique in their ability to deliver nucleic acids based on the recognition of a validated marker expressed by cancer cells.

Quiet Therapeutics Headquarters Location

7 Pinchas Sapi 5th Floor

Ness Ziona, 74140,

Israel

972-74-703-3631

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Quiet Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Quiet Therapeutics is included in 3 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Quiet Therapeutics Patents

Quiet Therapeutics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/14/2013

3/27/2018

RNA, Molecular biology, RNA interference, Gene expression, MicroRNA

Grant

Application Date

3/14/2013

Grant Date

3/27/2018

Title

Related Topics

RNA, Molecular biology, RNA interference, Gene expression, MicroRNA

Status

Grant

  • Where is Quiet Therapeutics's headquarters?

    Quiet Therapeutics's headquarters is located at 7 Pinchas Sapi, Ness Ziona.

  • What is Quiet Therapeutics's latest funding round?

    Quiet Therapeutics's latest funding round is Series A.

  • How much did Quiet Therapeutics raise?

    Quiet Therapeutics raised a total of $5.5M.

  • Who are the investors of Quiet Therapeutics?

    Investors of Quiet Therapeutics include Pontifax and Arkin Holdings.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.